News & Updates
Showing Cardiology articles
Showing
Show Multimedia Only

Add-on evolocumab improves plaque characteristics in statin-treated CAD patients
15 Mar 2023
byAudrey Abella
In individuals with stable coronary artery disease (CAD), intensifying their lipid-lowering regimen with evolocumab, a PCSK9* inhibitor, led to improvements in coronary plaque characteristics on intravascular imaging, findings from the YELLOW III trial have shown.
15 Mar 2023

STELLAR trial offers hope for rare heart-lung disorder
13 Mar 2023
byAudrey Abella
The phase III STELLAR trial lives up to its name, delivering stellar results and offering hope for patients with pulmonary arterial hypertension (PAH), a rare, progressive, life-threatening disorder affecting the heart and lungs, by adding sotatercept – a novel first-in-class activin signalling inhibitor – to background therapy.
13 Mar 2023






